AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with Market Growth from $9.
8 Billion in 2024 to $33.5 Billion by 2029 BOSTON , Sept. 26, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for " Artificial Intelligence (AI) in Life Sciences Market " is estimated to grow from $9.
8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.
" The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences, highlighting key trends and regional dynamics that are shaping the future of this transformative field.
This report is particularly relevant at this moment due to the rapid advancements and accelerating adoption of artificial intelligence within the life sciences industry. As the volume and complexity of biological data continue to increase, there is a pressing need for innovative technologies that can enhance our ability to understand, diagnose, and treat various diseases. AI i.
